MedPath

Effect on Craving in Individuals with Alcohol Use Disorder

Phase 2
Conditions
Health Condition 1: F102- Alcohol dependence
Registration Number
CTRI/2023/12/060972
Lead Sponsor
Postgraduate Institute of Medical Education and Research Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Providing written informed consent

2.A diagnosis of Alcohol Use Disorder as per DSM 5 TR.

3.A minimum 4 weeks of maintenance treatment on Naltrexone or Acamprosate or Baclofen or Topiramate

4.Subjective report of Craving severity greater than 2 on the 5-point Visual Analogue Scale

Exclusion Criteria

1.Patients with comorbid substance use disorders other than Alcohol and Nicotine.

2.Patients with primary psychotic or primary mood disorders.

3.Patients with a neurological disorder like multiple sclerosis, stroke, epilepsy, or encephalopathy due to any cause.

4.Patients with any intracranial metallic and electric implants.

5.Patients with comorbid organic brain syndrome and intellectual disability.

6.Pregnant and lactating females.

7.Any electronic or metallic implant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath